Treatments

Metformin reduces COVID-19 viral load, viral rebound--study

Fri, 2024-05-03 11:00 — mike kraft

Study finds metformin reduces COVID-19 viral load, viral rebound

A team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, can decrease the amount of COVID-19 virus in the body and lower the chances of the virus coming back strongly after initial treatment. The study was published in Clinical Infectious Diseases.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Metformin reduces COVID-19 viral load, viral rebound--study
Log in or register to post comments

U.S. COVID-19 hospitalizations hit record low - CDC

Tue, 2024-04-30 19:06 — mike kraft

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. COVID-19 hospitalizations hit record low - CDC
Log in or register to post comments

Studies indicate COVID may have eroded doctors' belief that they are obligated to treat infectious patients

Fri, 2024-04-26 10:35 — mike kraft

COVID may have eroded doctors' belief that they are obligated to treat infectious patients A systematic review posted in Clinical Infectious Diseases reveals that, amid the COVID-19 pandemic, many physicians felt less ethically obligated to provide care to infectious-disease patients if they fear contracting the disease. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days --study

Fri, 2024-04-26 09:49 — mike kraft

Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days Taking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19 symptom onset—not earlier or later—may result in the greatest reduction in viral loads, viral transmission, and viral rebound in hospitalized patients, a University of Hong Kong–led study finds. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days --study
Log in or register to post comments

WHO study estimates Global immunization efforts have saved at least 154 million lives over the past 50 years

Wed, 2024-04-24 19:06 — mike kraft

Global immunization efforts have saved at least 154 million lives over the past 50 years A major landmark study reveals that global immunization efforts have saved an estimated 154 million lives – or the equivalent of 6 lives every minute of every year – over the past 50 years. The vast majority of lives saved – 101 million – were those of infants.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

COVID-19 guidelines: Most countries recommend at least one treatment that doesn't work--study

Tue, 2024-04-23 10:04 — mike kraft

Significant global variation in COVID-19 guidelines: Most countries recommend at least one treatment that doesn't work National clinical guidelines for the treatment of COVID-19 vary significantly around the world, with under-resourced countries the most likely to diverge from gold standard (World Health Organization; ... Science X Medical Xpress

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID-19 guidelines: Most countries recommend at least one treatment that doesn't work--study
Log in or register to post comments

Remdesivir cut death risk by up to 25% in adults with COVID and no added oxygen

Wed, 2024-04-17 17:54 — mike kraft

Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen The antiviral drug remdesivir cut death rates 17% to 25% in adults hospitalized for COVID-19 who didn't require supplemental oxygen at admission, suggests a large US study published yesterday in Open Forum Infectious Diseases. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Remdesivir cut death risk by up to 25% in adults with COVID and no added oxygen
Log in or register to post comments

EU’s Covid recovery fund under pressure to allocate unused funds

Tue, 2024-04-09 09:23 — mike kraft

€500B remains unspent from EU’s Covid recovery fund Capitals urge European Commission to slash red tape fearing that huge amounts of money won’t ever be used. POLITICO

BRUSSELS — Governments have received less than a third of the EU's original €723 billion pot to help boost post-Covid economic recovery and are now heaping pressure on the European Commission to speed up payments.

Country / Region Tags:

General Topic Tags: